1. Home
  2. ATYR vs CCRN Comparison

ATYR vs CCRN Comparison

Compare ATYR & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • CCRN
  • Stock Information
  • Founded
  • ATYR 2005
  • CCRN 1986
  • Country
  • ATYR United States
  • CCRN United States
  • Employees
  • ATYR N/A
  • CCRN N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • CCRN Professional Services
  • Sector
  • ATYR Health Care
  • CCRN Consumer Discretionary
  • Exchange
  • ATYR Nasdaq
  • CCRN Nasdaq
  • Market Cap
  • ATYR 451.3M
  • CCRN 447.2M
  • IPO Year
  • ATYR 2015
  • CCRN N/A
  • Fundamental
  • Price
  • ATYR $5.48
  • CCRN $12.60
  • Analyst Decision
  • ATYR Strong Buy
  • CCRN Hold
  • Analyst Count
  • ATYR 6
  • CCRN 5
  • Target Price
  • ATYR $20.20
  • CCRN $17.93
  • AVG Volume (30 Days)
  • ATYR 3.6M
  • CCRN 254.7K
  • Earning Date
  • ATYR 08-12-2025
  • CCRN 07-30-2025
  • Dividend Yield
  • ATYR N/A
  • CCRN N/A
  • EPS Growth
  • ATYR N/A
  • CCRN N/A
  • EPS
  • ATYR N/A
  • CCRN N/A
  • Revenue
  • ATYR N/A
  • CCRN $1,258,238,000.00
  • Revenue This Year
  • ATYR $960.85
  • CCRN N/A
  • Revenue Next Year
  • ATYR $1,283.47
  • CCRN $5.69
  • P/E Ratio
  • ATYR N/A
  • CCRN N/A
  • Revenue Growth
  • ATYR N/A
  • CCRN N/A
  • 52 Week Low
  • ATYR $1.48
  • CCRN $9.58
  • 52 Week High
  • ATYR $5.98
  • CCRN $18.50
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 56.44
  • CCRN 38.44
  • Support Level
  • ATYR $4.96
  • CCRN $12.68
  • Resistance Level
  • ATYR $5.45
  • CCRN $13.60
  • Average True Range (ATR)
  • ATYR 0.36
  • CCRN 0.48
  • MACD
  • ATYR -0.06
  • CCRN -0.04
  • Stochastic Oscillator
  • ATYR 60.42
  • CCRN 4.39

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Share on Social Networks: